Organigram invests $21M in Sanity Group, a leading German cannabis company, to expand in Europe's cannabis market.
Organigram Holdings, a Canadian cannabis company, has invested $21M in Sanity Group, a leading German cannabis company, aiming to expand its presence in Europe's cannabis market. Sanity Group holds a 10% market share in Germany's medical cannabis sector and is involved in Switzerland's recreational pot pilot. The investment allows Organigram to appoint a representative to Sanity's board.
June 25, 2024
9 Articles